Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Addition of Dexmedetomidine to Morphine Improve the Treatment of Pain in Patients With Metastatic Cancer? A Pilot Study

NCT03936205 is registered in ClinicalTrials.gov with Hotel Dieu de France Hospital as lead sponsor.

NCT NCT03936205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03936205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Addition of Dexmedetomidine to Morphine Improve the Treatment of Pain in Patients With Metastatic Cancer? A Pilot Study
Lead sponsor
Hotel Dieu de France Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2016
Completion date
October 31, 2017
Enrollment
18 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, refractory pain